MAIA Biotechnology, Inc.
MAIA · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $6,357 | $3,111 | $3,198 | $2,969 |
| G&A Expenses | $3,004 | $2,055 | $2,228 | $2,036 |
| SG&A Expenses | $3,004 | $2,055 | $2,228 | $2,036 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | -$0 |
| Operating Expenses | $9,361 | $5,166 | $5,425 | $5,005 |
| Operating Income | -$9,361 | -$5,166 | -$5,425 | -$5,005 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $458 | -$181 | $908 | $1,433 |
| Pre-Tax Income | -$8,903 | -$5,347 | -$4,517 | -$3,572 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8,903 | -$5,347 | -$4,517 | -$3,572 |
| % Margin | – | – | – | – |
| EPS | -0.27 | -0.18 | -0.16 | -0.14 |
| % Growth | -50% | -12.5% | -14.3% | – |
| EPS Diluted | -0.27 | -0.18 | -0.16 | -0.14 |
| Weighted Avg Shares Out | 33,202 | 30,300 | 27,697 | 26,158 |
| Weighted Avg Shares Out Dil | 33,202 | 30,300 | 27,697 | 26,158 |
| Supplemental Information | – | – | – | – |
| Interest Income | $78 | $80 | $82 | $80 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $9,361 | $0 | $0 | $5,005 |
| EBITDA | $458 | -$5,166 | -$5,425 | $0 |
| % Margin | – | – | – | – |